You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

intra hepatocellular lipid

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Frankfurt, Hannover, Jena (Delcath Hepatic Delivery System,

Terminated
  • Hepatocellular Carcinoma
  • Intrahepatic Cholangiocarcinoma
  • Frankfurt, Germany
  • +2 more
Oct 13, 2022

Hepatocellular Carcinoma Trial in France (QuiremSpheres)

Recruiting
  • Hepatocellular Carcinoma
  • QuiremSpheres
  • Clichy, France
  • +3 more
Jan 27, 2023

Intra-arterial Perfusion in Interventional Radiology

Recruiting
  • Hepatocellular Carcinoma
  • Intra-arterial Perfusion
  • Palo Alto, California
    VA Palo Alto Health Care System
Jul 15, 2022

Carcinoma, Hepatocellular Trial in France (Idarubicin and Lipiodol)

Recruiting
  • Carcinoma, Hepatocellular
  • Idarubicin and Lipiodol
  • Angers, France
  • +3 more
Dec 24, 2021

Hepatocellular Cancer Trial in Dallas (Oncozene-DEB-TACE)

Active, not recruiting
  • Hepatocellular Cancer
  • Oncozene-DEB-TACE
  • Dallas, Texas
    UT Southwestern Medical Center
Aug 27, 2021

Hepatocellular Carcinomas Trial in Rennes (188Re-SSS Lipiodol)

Completed
  • Hepatocellular Carcinomas
  • 188Re-SSS Lipiodol
  • Rennes, France
    Centre Eugene Marquis
Jul 26, 2021

Hepatocellular Carcinoma (HCC) Trial in Taiwan, United States (IA therapy of HCC with CSR02-Fab-TF)

Recruiting
  • Hepatocellular Carcinoma (HCC)
  • IA therapy of HCC with CSR02-Fab-TF
  • Saint Louis, Missouri
  • +6 more
Aug 16, 2022

Hepatocellular Carcinoma Trial in Villejuif (Nivolumab, Ipilimumab)

Recruiting
  • Hepatocellular Carcinoma
  • Villejuif, France
    Gustave Roussy
Mar 29, 2021

Clinical Trajectory of Resected Hepatocellular Carcinoma

Completed
  • Hepatocellular Carcinoma
    • Kuala Lumpur, Malaysia
    • +5 more
    Jun 7, 2021

    Hepatocellular Carcinoma, Solid Tumor, Adult Trial in Guangzhou (Injection of drug-eluting microspheres into malignant tumors)

    Recruiting
    • Hepatocellular Carcinoma
    • Solid Tumor, Adult
    • Injection of drug-eluting microspheres into malignant tumors
    • Guangzhou, Guangdong, China
      The Second Affiliated Hospital of Guangzhou Medical University
    Apr 6, 2021

    Hepatocellular Carcinoma, Liver Cancer, Liver Tumors Trial in Xi'an (ET1402L1-ARTEMIS™ T cells -IV, ET1402L1-ARTEMIS™ T cells

    Completed
    • Hepatocellular Carcinoma
    • +3 more
    • ET1402L1-ARTEMIS™ T cells -IV
    • +2 more
    • Xi'an, China
      The First Affiliated Hospital of Xi'an Jiaotong University
    Mar 26, 2021

    Hepatocellular Carcinoma Trial in Toronto (CT perfusion, Norepinephrine intra-arteriel/hepatic)

    Completed
    • Hepatocellular Carcinoma
    • CT perfusion
    • Norepinephrine intra-arteriel/hepatic
    • Toronto, Ontario, Canada
      Toronto General Hospital
    Apr 26, 2021

    Metastatic Liver Carcinoma, Stage IV Liver Cancer, Stage IVA Liver Cancer Trial in Houston (procedure, radiation, other)

    Active, not recruiting
    • Metastatic Liver Carcinoma
    • +3 more
    • Angiography
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 22, 2022

    Carcinoma, Carcinoma, Hepatocellular, Liver Tumor Trial in Spokane (99mTc-Macro Albumin Aggregate)

    Recruiting
    • Carcinoma
    • +2 more
    • 99mTc-Macro Albumin Aggregate
    • Spokane, Washington
      Inland Imaging
    May 4, 2023

    Unresectable Hepatocellular Carcinoma Trial in Worldwide (TheraSphere)

    Completed
    • Unresectable Hepatocellular Carcinoma
    • TheraSphere
    • Phoenix, Arizona
    • +93 more
    Jan 19, 2023

    Cirrhosis Trial in Houston (Contrast-Enhanced Ultrasound, Sulfur Hexafluoride Lipid Microspheres, Ultrasound)

    Completed
    • Cirrhosis
    • Contrast-Enhanced Ultrasound
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 11, 2020

    Diabetes, Type 2 Trial (Dietary intervention)

    Not yet recruiting
    • Diabetes Mellitus, Type 2
    • Dietary intervention
    • (no location specified)
    Sep 27, 2022

    Morbid Obesity, Liver Fat Trial in London (dietary supplement, procedure, other)

    Completed
    Has Results
    • Morbid Obesity
    • Liver Fat
    • Liquid formula low-calorie diet (LCD)
    • +2 more
    • London, Greater London, United Kingdom
      Imperial Clinical research facility
    Feb 24, 2021

    Sickle Cell Disease, Dyslipidemia, Complication Trial in Pointe-à-Pitre, Le Lamentin (HDL2)

    Recruiting
    • Sickle Cell Disease
    • +2 more
    • HDL2
    • Pointe-à-Pitre, Guadeloupe, France
    • +1 more
    Mar 21, 2023

    Patterns of Transcatheter Arterial Chemoembolization Combined

    Not yet recruiting
    • HCC
    • (no location specified)
    Aug 29, 2023

    Liver Diseases, Hepatocellular Carcinoma, Immunotherapy Trial in Guangzhou (bTAE-HAIC, Lenvatinib, Sintilimab)

    Not yet recruiting
    • Liver Diseases
    • +4 more
    • bTAE-HAIC
    • +2 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Sep 30, 2023

    Liver Cancer, Hepatocellular Carcinoma Trial in Chengdu (HBV mRNA vaccine)

    Recruiting
    • Liver Cancer
    • Hepatocellular Carcinoma
    • HBV mRNA vaccine
    • Chengdu, Sichuan, China
      West China Hospital, Sichuan University
    Feb 12, 2023

    Precision Medicine for Combined

    Recruiting
    • Liver Cancer
    • phenotyping
    • Créteil, France
      Julien Calderaro
    Nov 17, 2023

    Liver Diseases, Hepatocellular Carcinoma, Immunotherapy Trial in Guanzhou (bTAE-HAIC, Lenvatinib, Camrelizumab)

    Not yet recruiting
    • Liver Diseases
    • +4 more
    • bTAE-HAIC
    • +2 more
    • Guanzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Sep 24, 2023

    Hepatocellular Carcinoma Trial in Philadelphia (Hydroxychloroquine, Lipiodol, Placebo)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • Philadelphia, Pennsylvania
      Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
    Apr 21, 2023